-+ 0.00%
-+ 0.00%
-+ 0.00%

*EyePoint: Phase 3 DME Clinical Trials, COMO and CAPRI, Rapidly Advancing With Over One-Third of Patients Enrolled>EYPT

Dow Jones·05/06/2026 11:07:00

Please log in to view news